Breakthroughs in Chronic Lymphocytic Leukemia from ASH 2011 (video)
Steven Rosen, MD, shares his perspective about the latest chronic lymphocytic leukemia (CLL) news from the American Society of Hematology's 2011 annual meeting. Dr. Rosen explores CLL breakthroughs, including a new, non-chemotherapy treatment that may provide a better tolerated approach to treating the disease, especially for older patients and those with genetic variations that do not respond to the current standard of care.
Steven Rosen, MD, is an oncologist and hematologist. He is the director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and director of cancer programs at Northwestern Memorial Hospital.